TAK
Takeda Pharmaceutical Co Ltd ADR
NYSE: TAK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$16.68
+2.33% today
Updated 2026-04-30
Market cap
$52.70B
P/E ratio
75.82
P/S ratio
0.01x
EPS (TTM)
$0.22
Dividend yield
3.96%
52W range
$13 – $19
Volume
2.8M
Takeda Pharmaceutical Co Ltd ADR (TAK) Financial statements
SEC filings — annual and quarterly data.
Profit margin
2.53%
Operating margin
10.80%
ROE
1.50%
ROA
2.47%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $1.21T | $313.25B | 76.73% | 33.23% | 25.84% |
| 2007 | $1.31T | $335.81B | 78.57% | 35.13% | 25.73% |
| 2008 | $1.37T | $355.45B | 79.73% | 30.78% | 25.85% |
| 2009 | $1.54T | $234.38B | 81.18% | 19.92% | 15.24% |
| 2010 | $1.47T | $297.74B | 80.55% | 28.66% | 20.31% |
| 2011 | $1.42T | $247.87B | 77.63% | 25.86% | 17.46% |
| 2012 | $1.51T | $124.16B | 71.29% | 17.56% | 8.23% |
| 2013 | $1.56T | $131.24B | 71.26% | 7.87% | 8.43% |
| 2014 | $1.69T | $106.66B | 71.02% | 8.23% | 6.30% |
| 2015 | $1.78T | $-145.78B | 70.70% | -7.27% | -8.20% |
| 2016 | $1.81T | $80.17B | 70.38% | 7.24% | 4.44% |
| 2017 | $1.73T | $114.94B | 67.74% | 9.00% | 6.64% |
| 2018 | $1.77T | $186.89B | 71.99% | 13.66% | 10.56% |
| 2019 | $2.10T | $109.13B | 68.54% | 9.77% | 5.20% |
| 2020 | $3.29T | $44.24B | 66.89% | 3.05% | 1.34% |
| 2021 | $3.20T | $376.00B | 68.91% | 15.93% | 11.76% |
| 2022 | $3.57T | $230.06B | 68.99% | 12.91% | 6.45% |
| 2023 | $4.03T | $317.02B | 69.11% | 12.18% | 7.87% |
| 2024 | $4.26T | $144.07B | 66.43% | 5.02% | 3.38% |
| 2025 | $4.58T | $107.93B | 65.51% | 7.48% | 2.36% |